Strong volume growth blunted by raw material inflation; margin recovery at risk
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade C
Guided 10-11% OPM for FY27, delivered 6.6% in Q2 (Q1 was 6.8%). Margin recovery claim now at severe risk due to RM inflation persistence.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
JK Tyre delivered strong volume growth (+20.7% YoY revenue, +22% domestic volumes) into resilient demand, but gross profitability collapsed. OPM came in at 6.6% vs 10-11% full-year guidance, a miss management cannot credibly recover from given 4-5% further RM inflation expected in Q3 and incomplete pricing pass-through. Capex is being halved to ~₹1,300 Cr, restraining capacity growth. Demand trajectory is healthy; execution on margins is not.
₹4840.7 Cr
Revenue · +20.7% YoY₹65.1 Cr
Reported PAT · −71.3% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Highest-ever consolidated revenue of ₹4,850 Cr, up 20% YoY
METReported revenue ₹4,840.7 Cr, YoY growth 20.7%. Claim aligned with delivered result.
EBITDA margin of 7.1% in Q2 vs 6.8% in Q1, showing improvement
OVERSTATEDOPM delivered at 6.6%, below both EBITDA margin claims and far below 10-11% full-year guidance. Sequential margin improvement real but insufficient.
H2 margin recovery to 11-13% if RM costs stabilize
MISSQ2 OPM at 6.6%; management expects 4-5% further RM inflation in Q3. Stabilization not occurring, recovery highly unlikely.
Operating efficiencies and pricing will offset cost pressures
OVERSTATED7% pricing in Q2 + 4-5% planned for Q3 insufficient; RM costs up 9% QoQ, 22% vs Q1FY27. Margin still compressing.
Earnings quality
What changed since the last call
Operating margin guidance
DowngradeGuided 10-11% OPM for FY27 in Q1; Q2 delivered 6.6%, Q1 was 6.8%. H2 recovery to 11-13% now unachievable. Implicit downward revision to ~7-8% full year.
Capex trajectory
DowngradePrior ₹4,980 Cr multi-year plan now revised to ₹1,300 Cr for FY27 alone (₹800 Cr done, ₹500 Cr remaining). Significant moderation.
Raw material cost outlook
DowngradeRM costs up 22% since Q1; expected to inflate 4-5% further in Q3. No stabilization visible despite prior H2 margin recovery assumption.
Volume momentum
UpgradeDomestic volumes +22% YoY; OEM +25%, replacement +20%. EV volumes surged 24% QoQ. OE-market driven growth broadening across TBR, PLR, 2/3W segments.
The Q&A
Analysts pressed hard on margin recovery timeline (Abhishek Maheshwari, SkyRidge) and capex guidance (Tanish Nahar, Vijay Pandey). Management held firm on demand resilience but became evasive on margin recovery, citing unabsorbed costs and lag in pricing pass-through. No explicit walkback of 10-11% OPM guidance, but tone was defensive.
Europe export opportunity — Sarthak Jain, Desveldao Advisory
AnsweredYes, evaluating India-U.K. trade tariff agreement. Developing Europe-specific SKUs and already supplying parts via exports. Will take advantage of FTA and ramp up.
Raw material inflation & pricing — Deepak Malhotra, CapGrow Capital Advisors
AnsweredRM costs up 9% QoQ, 22% since Q1. Crude oil-linked costs (carbon black, synthetic rubber, steel cord) all up on Y-o-Y and Q-o-Q basis. Expected 4-5% further increase in Q3. Pricing increases already delivered 7% QoQ, with 4-5% more planned NSR in Q3-Q4. Unabsorbed delta continues to pressure margins.
Standalone vs consolidated financials — Vijay Pandey, Axis Capital
PartialConsolidated other expenses increased ~INR100 Cr QoQ. In standalone, RM basket increased 270 basis points. At consolidated level, margin broadly flat. Manufacturing in India for Mexico exports; customer billing done from Mexico subsidiary.
Volume guidance & capex returns — Tanish Nahar, Nahar Finance and Investments
AnsweredRemaining capex ~INR500 Cr for balance period. Volume growth on capex is ~1:1 asset turn; 1:1 can be considered for future revenues.
Farm and tractor segment pressure — Aman Ki, Individual Investor
PartialSeeing some traction from farm sector; rural income saw positive offshoots but also deficit in some agriculture sectors. Mixed signals. Supply ready for OEMs at large; no major demand disruption expected.
EBITDA margin trajectory — Abhishek Maheshwari, SkyRidge Fund Managers
DodgedUnabsorbed cost from RM increase and lag in pricing pass-through. Delta unabsorbed. Some basic points in Q3 for margin improvement; focused on cost efficiencies and utilization. Demand healthy, competitive pricing challenge in replacement market.
Q3 replacement market outlook — Disha Shah, Shah Capital
AnsweredReplacement market healthy growth momentum. Category-wise: truck/bus ~56%, PLR ~28%, 2-wheeler/3-wheeler ~6%, non-truck bias ~10% of standalone revenue. High single digit coming in medium-term TBR outlook.
Guidance
FY27 double-digit growth (10-11%+), tracking on delivered 20.7% H1 base
HighH1 revenue ₹4,026 Cr + ₹4,841 Cr = ₹8,867 Cr. On pace for double-digit FY27 growth vs ₹40,000+ Cr base (estimate).
OPM 10-11% for full year; H2 recovery to 11-13% if RM stabilizes
LowQ2 delivered 6.6% OPM (Q1 was 6.8%). RM inflation expected 4-5% further in Q3. Margin recovery unachievable without RM deflation or step-function pricing (unlikely). Implicit downgrade to 7-8% FY27.
FY27 capex ₹1,300 Cr total (₹800 Cr done, ₹500 Cr remaining)
HighMulti-year guidance was ₹4,980 Cr adding 7% capacity by FY28, 24% by 2029. FY27 spend revised down significantly; indicates deferrals or margin-driven constraints.
Risks the call surfaced
Raw material cost inflation
HighRM costs (crude oil, carbon black, synthetic rubber, steel cord) up 22% since Q1 and 9% QoQ in Q2. Management expects 4-5% further increase in Q3. Unabsorbed cost delta is eroding margins despite volume growth.
Margin recovery uncertainty
HighGuided OPM of 10-11% for FY27 now at severe risk. Q2 delivered only 6.6% (Q1: 6.8%). H2 margin recovery to 11-13% unachievable given 4-5% expected RM inflation. Full-year OPM likely 7-8% or lower.
Geopolitical supply chain disruption
MediumWest Asia conflict ongoing; freight, shipping costs remain elevated. Supply chain constraints persist. Crude oil prices volatile. If escalation spreads, input costs and demand could face further headwinds.
Capex deferrals & capacity growth risk
MediumMulti-year capex guidance ₹4,980 Cr (to add 7% capacity by FY28, 24% by 2029) now appearing at risk. FY27 spend revised to ₹1,300 Cr (₹800 Cr done, ₹500 Cr remaining), a significant moderation. Margin pressure may force further deferrals.
Competitive pricing power in replacement market
MediumReplacement market is highly competitive; pricing pass-through is capped. OEM market (indexed) easier to pass through. If RM costs continue to rise but replacement market pricing caps out, margins will compress further.
Management
Score 7/10. Clear on segment volumes, market trends, and cost drivers. Evasive on margin recovery timeline; did not reaffirm 10-11% OPM guidance or 11-13% H2 recovery despite prior claims. Transparent on RM inflation scale (22% since Q1, 9% QoQ, 4-5% expected Q3). Revenue growth on track (20.7% YoY, double-digit FY27 pacing). Volumes strong across segments. Pricing actions initiated (7% Q2, 4-5% more Q3-Q4). Margin recovery missing: OPM 6.6% vs 10-11% guided. Capex guidance cut significantly (₹1,300 Cr FY27 vs ₹4,980 Cr multi-year).
1 · Q3 FY27 (Dec 2026)
Crude oil prices stabilize; RM inflation moderates from 4-5% guidance
2 · H2 FY27
Further 4-5% NSR increases planned; pricing lag narrows if RM deflates
3 · CY2026-27
JK Tornel Mexico ramp-up to normal sales post-restart; EV volumes continue +24% growth
Demand trajectory is healthy; execution on margins is not.
JK Tyre Q2FY27: consolidated PAT falls 71% YoY to ₹65 Cr despite record ₹4,841 Cr revenue
PAT -71.32% YoY · revenue +20.68% · margins compressing
₹4,840.73 Cr
+20.68% YoY
₹65.07 Cr
-71.32% YoY
1.34%
-4.3pp YoY
₹2.29
JK Tyre's consolidated revenue hit a record ₹4,840.73 Cr for the quarter, up 20.7% YoY and 22.7% QoQ, but consolidated PAT fell to ₹65.07 Cr, down 71.3% YoY from ₹226.86 Cr a year ago (up 47.6% QoQ off Q1's depressed ₹44.09 Cr base). Standalone PAT was ₹60.68 Cr on standalone revenue of ₹4,452.06 Cr. Stripping out exceptional items on both sides (this quarter's ₹6.15 Cr FX loss plus ₹6.16 Cr VRS cost vs a ₹7.48 Cr net exceptional charge a year ago), the YoY PAT decline narrows only to roughly -67%, confirming the drop is driven by underlying margin pressure, not one-offs.
Q2 FY-2027 vs prior quarters
EBITDA margin came in at 7.1% (₹343 Cr EBITDA), down sharply from 12.8% a year ago, though up from 6.8% in Q1FY27 (EBITDA +28% QoQ). Net profit margin compressed to 1.3% from 5.6% YoY. Management attributes the squeeze to persistently elevated raw-material costs and container freight rates "significantly above historical levels," plus a "challenging" operating environment from geopolitical tensions in West Asia. Mexico subsidiary JK Tornel contributed ₹479 Cr of revenue this quarter, which the company calls a rebound after prior pressure.
The stock went into the print at ₹309.15, down 10.8% over the past month of trading.
For context: revenue is at a 6-quarter high.
FY27 revenue double-digit growth (10-11%, similar to FY26); operating margin 10-11% full year (vs 10.9% Q1FY26 but down from historical 11-13%); H2 margin recovery to 11-13% if RM costs stabilize; ₹4,980 Cr capex adding 7% capacity by FY28, 24% by 2029.
— This quarter: missed
Against management's own August 2026 guidance of FY27 revenue growth of 10-11% and full-year operating margin of 10-11% (with H2 recovery to 11-13% contingent on RM costs stabilizing), this quarter's 20.7% YoY revenue growth — fuelled by GST 2.0-led demand (OE market +65% YoY, domestic sales +32% YoY per the press release) — comfortably beats the topline guidance, but H1FY27 operating margin of roughly 6.9% sits well below the 10-11% full-year target, leaving the promised H2 margin recovery unproven two quarters in. No Q2-specific Street estimate was found; full-year FY27 consensus (sharpely.in) had pencilled in roughly 15-20% PAT growth, a bar that looks increasingly stretched after H1FY27 PAT of ₹109.16 Cr versus ₹390.21 Cr a year earlier (-72% YoY). Separately, the company disclosed a ₹94.86 Cr GST show-cause notice on October 13, 2026, which does not appear reflected as a provision in this quarter's exceptional items.
W1
H2FY27 margin recovery toward the guided 11-13% band, contingent on RM cost stabilization — H1FY27 OPM is running near 6.9%, well below the 10-11% full-year guidance
W2
Resolution/provisioning of the ₹94.86 Cr GST show-cause notice received October 13, 2026
W3
Sustainability of the JK Tornel (Mexico) revenue rebound to ₹479 Cr into H2, and of the post-GST-2.0 domestic demand surge
Consolidated profitAfterTax (65.07) is 'Profit for the period (X+XI)' = PAT after tax (59.99) + share of profit of associates (5.08), matching the basis used for the comparison-context figures (Q1FY27 44.09, Q2FY26 226.86); the press release's '60 Cr' PAT headline is the pre-associate-share figure. Exceptional items present both periods (FX loss + VRS cost this quarter vs net FX/VRS charge a year ago) — adjustedPatYoYPct strips these pre-tax.
Record Revenue, Margin Miss: The Cost of Inflation JK Tyre Can't Pass Through
Q2 hit an all-time high of ₹4,841 Cr in revenue—extending a strong 20.7% YoY growth—but operating margin collapsed to 6.6%, blowing past management's 10–11% full-year promise. Raw material inflation of 22% since Q1 and a pricing lag have made that guidance unachievable.
₹4,841 Cr
+20.7% YoY, highest-ever
6.6%
vs 10–11% guided; Q1 was 6.8%
₹65.1 Cr
-71.3% YoY; NPM 1.3%
+22% YoY
OEM +25%, replacement +20%
On the headline, Q2 looks like a victory lap. Highest-ever revenue, strong double-digit growth, demand resilience across segments—OEM surging 25%, replacement 20%, EV volumes up 24% quarter-on-quarter. But the profit story is inverted. Net profit crashed 71.3% year-on-year, and operating margin sits at 6.6%, nowhere near the 10–11% management promised for the full year. The quarter reveals what happens when raw material inflation moves faster than your pricing power.
Where the margin went
The arithmetic is stark. Raw material costs—crude oil–linked inputs like carbon black, synthetic rubber, and steel cord—have inflated 22% since Q1 FY27. In Q2 alone, that was a 9% sequential jump. Management raised prices 7% in Q2 and plans another 4–5% increase in Q3–Q4. But when you subtract pricing from cost inflation, the delta gets absorbed into margin. The proof is in the trend: OPM fell from 6.8% in Q1 to 6.6% in Q2, even as volumes grew 22%. That is the first crack in the guidance edifice. And it is widening—management expects 4–5% further raw material inflation in Q3, with no stabilization of crude oil or freight costs in sight due to ongoing geopolitical disruption.
We have seen the raw material whole basket increased by 9% on a Q-o-Q basis, which is on a Q1 to Q2 basis... Cumulatively, we have seen a staggering 30% increase in the last 6 months.
Management's claims on the call—what holds up
Highest-ever consolidated revenue of ₹4,850 Cr, up 20% YoY
SupportedReported revenue ₹4,840.7 Cr, YoY growth 20.7%. Alignment is close.
EBITDA margin of 7.1% in Q2 vs 6.8% in Q1, showing improvement
OverstatedOPM delivered 6.6%, below both EBITDA claims and far below 10–11% full-year guidance. Sequential improvement real but insufficient.
H2 margin recovery to 11–13% if RM costs stabilize
ContradictedQ2 OPM at 6.6%; management expects 4–5% further RM inflation in Q3. Stabilization not occurring, recovery highly unlikely.
Operating efficiencies and pricing will offset cost pressures
Overstated7% pricing in Q2 + planned 4–5% for Q3 are insufficient; RM costs up 9% QoQ, 22% vs Q1. Margin still compressing despite volume growth.
What changed on this call
Three things shifted from prior guidance, each material. First, capex. The company cited a multi-year plan of ₹4,980 Cr to add 7% capacity by FY28 and 24% by 2029. FY27 capex is now tracking at ~₹1,300 Cr (₹800 Cr done, ₹500 Cr remaining)—a significant moderation. When margins squeeze, capex defers. Second, margin guidance. Management did not walk back the 10–11% OPM target explicitly, but the tone was defensive. The claim of H2 recovery to 11–13% 'if RM stabilizes' is now unsubstantiated given 4–5% further inflation expected in Q3. By the math, FY27 operating margin is locked into 7–8% or lower—an implicit downgrade of 200–400 basis points from guidance. Third, raw material outlook. The 4–5% further inflation forecast in Q3, combined with the West Asia geopolitical backdrop, suggests no stabilization is coming. The margin recovery narrative depends on crude oil stabilizing; that is not the base case the company is now operating from.
The bull case and the bear case
Demand resilience is genuine: +22% domestic volumes, OEM +25%, replacement +20%, EV surge +24% QoQ
Capacity utilization >90% across key segments (TBR, PLR, 2/3W); OEM market outpacing replacement
EV electrification tailwind is structural: premium tyre opportunity (16+ inch shift, 20% CAGR); new SKU launches (Tomahawk for MG Hector)
Long-term capex plan signals 7% capacity by FY28 and 24% by 2029—foundation for mid-term growth
Operating margin guidance of 10–11% is now unachievable; 22% RM inflation since Q1 and pricing lag suggest 7–8% is realistic for FY27
Capex deferrals risk long-term capacity expansion; if FY27 moderation extends into FY28, the 24% capacity growth by 2029 is at risk
Replacement market pricing power is capped; competitive intensity limits pricing pass-through despite OEM segment ease (indexed pricing)
Net debt rose ₹751 Cr QoQ to ₹5,696 Cr due to 30% RM inflation impact on inventory, capex, and working capital—balance sheet stress signal
Ranked risks—what should concern a holder
Raw material cost inflation continues to accelerate
HighRM costs up 22% since Q1; 4–5% further increase expected in Q3. Crude oil, carbon black, synthetic rubber, steel cord all linked to geopolitical disruption. If inflation exceeds 5% in Q3–Q4, margin targets fall deeper. Pricing lag in replacement market limits recovery.
OPM guidance miss becomes permanent
HighGuided 10–11% for FY27; Q2 delivered 6.6%. With 4–5% further RM inflation in Q3, H2 recovery to 11–13% is unachievable. Implicit downgrade to 7–8% for the full year is a ~300bp miss on expectations. Credibility hit is material.
Capex deferrals accelerate; capacity growth targets at risk
MediumFY27 capex revised to ₹1,300 Cr (from ₹4,980 Cr multi-year plan). If margin squeeze deepens, further deferrals are likely. The 7% capacity by FY28 and 24% by 2029 targets are now in jeopardy, constraining mid-term growth.
Geopolitical escalation prolongs freight and input cost pressures
MediumWest Asia conflict ongoing; shipping costs and crude oil volatility persist. If escalation spreads, RM inflation could exceed management's 4–5% Q3 forecast. Downside tail risk is real.
Replacement market demand softens due to macro tightening or rural income pressure
MediumFarm sector showing mixed signals already (rural income deficits in some segments). If macro tightens further, replacement demand growth (currently +20% YoY) could slow. That is the lower-margin segment; volume loss there would hurt.
How the street is reading it
The market is voting thumbs-down. FII ownership fell from 18.60% in Q4 FY26 to 15.75% in Q1 FY27—a 285 basis point outflow in a single quarter. That is not a cosmetic trim; institutions are trimming exposure. The stock itself is trading at ₹310.7, down 49% from its all-time high of ₹611.9. It sits below all major moving averages: SMA20 at ₹327.81, SMA50 at ₹348.56, and SMA200 at ₹412.63. The RSI at 33 is neutral (not yet oversold, but weak). What the price action says: the market is not giving JK Tyre credit for demand resilience. Instead, it is discounting the margin miss as a permanent downgrade—a step-change loss of profitability, not a temporary hiccup. The FII outflow validates that read: institutional investors are moving capital elsewhere. For a holder, that is a warning. The fundamental story (margin miss, capex cut, RM inflation persistence) is matching the technical and flow backdrop.
The honest debate
What to watch next—catalysts and key milestones
1 · Crude oil and raw material price stabilization (Q3 into Q4)
Management expects 4–5% further RM inflation in Q3, after which stabilization should kick in. If crude oil moderates or carbon black futures stabilize, the pricing window for Q3–Q4 becomes a real lever for margin recovery. This is the bull case catalyst. Watch spot prices and forward curves.
2 · Q3 pricing pass-through success (Jan 2027 earnings call)
Management has committed to 4–5% NSR (net selling rate) increases in Q3–Q4. But the replacement market is competitive; will they achieve those increases without losing volume? This is the margin recovery test. If Q3 pricing delivers full 4–5% realization and RM inflation does moderate, H2 OPM could stabilize at 8–9%. If pricing lags or volume declines, the guidance miss extends.
3 · Capex execution and FY28 capacity growth trajectory (Q3 and Q4 management updates)
The ₹500 Cr remaining capex for FY27 must be deployed. If deferrals deepen into FY28, the long-term 7% and 24% capacity targets are in jeopardy. Watch management commentary on capex intensity and returns on FY27 capex. This determines whether the mid-term growth runway is intact or at risk.
4 · JK Tornel (Mexico) recovery trajectory
The Mexico subsidiary is in recovery mode (post-restart capex and ramp). Q2 consolidated showed ₹479 Cr Mexico revenue with ₹23 Cr EBITDA. If Tornel reaches profitability and contributes positively to consolidated margins by Q4, it becomes a turnaround story. If losses persist or narrow slowly, it is a drag on FY27 consolidated OPM.
This quarter is a step-down, not a step-change. Demand volumes are robust and the EV electrification story is real. But the margin guidance miss—from 10–11% to likely 7–8% for FY27—is material and credibility-damaging. Management's H2 recovery claim (11–13%) is unsubstantiated by the data (4–5% further RM inflation expected). Capex is being moderated, which signals balance sheet stress and raises questions about long-term capacity growth. The stock is reflecting all of this: FII are exiting, and the price has fallen 49% from its all-time high.
The number to track from here is not revenue growth (that is well-established). It is OPM stabilization. When does operating margin stabilize above 8%? If Q3 and Q4 deliver pricing pass-through against moderating RM inflation, that milestone is achievable by year-end. If not—if margin stays compressed or falls further—the repricing is deeper than current prices suggest. The data will come in January 2027 (Q3 earnings). That is the test.